Europe Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

The Europe Hyperpigmentation Treatment Market would witness market growth of 7.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $567.4 million by 2030. The UK market is exhibiting a CAGR of 6.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 8.6% during (2023 - 2030).



One of the primary drivers behind the heightened adoption of hyperpigmentation treatments is the increased awareness of skincare practices. The proliferation of information through various channels, including social media, beauty blogs, and online forums, has educated consumers about different skin conditions and the available treatment options. As individuals become more informed about the causes and consequences of hyperpigmentation, they are more likely to seek professional solutions to address these concerns.

Changing beauty standards plays a pivotal role in the adoption of hyperpigmentation treatments. While a growing emphasis is on embracing diverse skin tones and celebrating natural beauty, the desire for clear, even skin remains a prevalent aesthetic goal. The evolving standards, marked by inclusivity and acceptance of various skin types, contribute to a broader audience seeking hyperpigmentation treatments to achieve skin clarity and uniformity. The availability of information significantly influences the growing use of hyperpigmentation treatments. Online resources provide individuals with a wealth of information about available treatment options, potential side effects, and real-life testimonials. This democratization of information empowers consumers to make informed decisions about their skincare, leading to a higher likelihood of seeking professional treatments for hyperpigmentation.

As per the data released by Eurostat, in 2022, the median equivalized disposable income in the EU was 18,706 purchasing power standards (PPS) per inhabitant, increasing from 18,011 PPS recorded in 2021. At the national level, the EU countries with the highest median disposable incomes in 2022 were Luxembourg (33 214 PPS), the Netherlands (25 437 PPS), Austria (25 119 PPS), Belgium (24 142 PPS), Denmark (23 244 PPS) and Germany (23 197 PPS). Thus, all these factors will boost the regional market’s expansion in the coming years.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Vivier Pharma Inc.
• Pierre Fabre S.A
• Aerolase
• L'Oréal S.A.
• CP Skin Health Group, Inc. (The Colgate Palmolive Company)
• Trophy Skin Products LLC
• The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
• Episciences, Inc.
• The Procter and Gamble Company
• Galderma S.A.

Market Report Segmentation

By Treatment Type

• Topical Agent
• Photo Therapy
• Microdermabrasion

By End User

• Dermatological Clinics
• Hospitals
• Others

By Disorder Type

• Melasma
• Age Spot
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe